Neuro-Oncology Reviews
Volume
28 Number 15
31 May 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 15, 31 May
Hall MD, Abdelbaki MS.
Treatment
deintensification in average-risk medulloblastoma: less is more?
Neuro
Oncol. 2026 May 22:noag118. doi:
10.1093/neuonc/noag118. PMID:
42172620˰ ˍ
Khasraw M, Dun MD, Arrillaga-Romany I, Verhaak RGW, Bouffet E,
Hansford JR, Singh K, Mueller S, Koschmann C, Wen PY.
Dordaviprone
for Diffuse Midline Glioma: A Landmark Approval or a Premature
Step?
Neuro
Oncol. 2026 May 22:noag117. doi:
10.1093/neuonc/noag117. PMID:
42172613. ˍ
Guild A, Mahapatra S, Raulji C, Karsonovich T, Amsbaugh MJ.
Medulloblastoma.
StatPearls
Publishing. 2026 May 23. Bookshelf
ID: NBK431069. PMID:
28613723. ˍ
*Izhar M, Hori YS, Lam FC, Kalra N, Zagzoog N, Tayag A, Ustrzynski
L, Emrich SC, Park DJ, Chang SD.
Clinical
utility of liquid biopsy in distinguishing true progression from
radiation necrosis and pseudoprogression in malignant brain tumor.
J
Neurooncol. 2026 May 25;178(1):21. doi:
10.1007/s11060-026-05618-z. PMID:
42185659˰ ˍ
Tomassen ML, Pronk CE, Deutsch E, Verhoeff JJC, Slotman BJ, van
Laarhoven HWM, Bahce I, Al-Mamgani A, de Gruijl TD, Senan S,
Schneiders FL, van Rossum PSN.
The
survival impact of combining radiotherapy and immune checkpoint
inhibitors in patients with solid tumors: A systematic review and
living meta-analysis of randomized controlled trials.
Eur
J Cancer. 2026 May 25;242:116820. doi:
10.1016/j.ejca.2026.116820. PMID:
42208279. ˍ
Wang W, Yuan Y, Sun R, Surau MK, Becker PA, Xu F, Burkutally MSN,
Chen Y, Chen L.
Status and trends in
glioblastoma lipid metabolism research: a bibliometric analysis.
Discov
Oncol. 2026 May 30. doi:
10.1007/s12672-026-05298-1. PMID:
42218291. ˍ
Rezaei-Tazangi F, Aliakbari F, Momeni Y, Mokari M, Zahiranpoor M,
Adinehpour M, Ansari S, Shirani F, Malmir A.
Research
trends in microRNAs in glioma tumors: A data-driven exploration
using a bibliometric approach.
IBRO
Neurosci Rep. 2026 Feb 28;20:694-702. doi:
10.1016/j.ibneur.2026.02.020. PMID:
42088537. ˍ
Greenland J, Kendrick J, Ebert MA, Mirzaei M, White R, Dass J,
Polpo A, Rowshanfarzad P.
Emerging
Outcome Trends From Proton Therapy for Pediatric CNS Tumors: A
Systematic Review.
Int
J Part Ther. 2026 Apr 23;20:101317. doi:
10.1016/j.ijpt.2026.101317. PMID:
42205855. ˍ
Leeper HE, Oliver K, Bulbeck H, Johnson MO.
Translating
Cancer Science Into Cancer Care: Using Serious Illness
Communication Frameworks to Deliver High-Quality Person-Centered
Care in Neuro-Oncology.
Am
Soc Clin Oncol Educ Book. 2026 May 8;46(3):e525426.
doi:
10.1200/EDBK-26-525426. PMID:
42102343. ˍ
Vargas LO, Latzman S, Tickoo L, Abikenari M, Syed SA, Mittelman L,
Cassimatis N, Teng CL, Sistiaga IL, D'Amico RS.
Gliomas
as network diseases: Neuron-tumor interactions, connectome
disruption, and clinical implications.
Clin
Neurol Neurosurg. 2026 May 11;267:109475. doi:
10.1016/j.clineuro.2026.109475. PMID:
42119240˰ ˍ